Delivery Order SPE2DB24D9155-SPE2DB25FHZHS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, under a firm fixed-price contract structure. This award represents no set-aside designation and reflects DMS Pharmaceutical Group's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, designated as a firm fixed-price delivery order, was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, operates under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Stelara 90 mg/ml syringes. The award, which carries no set-aside designation, is scheduled for completion by October 6, 2025, with fulfillment to occur at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this engagement. This...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 19, 2025, for the supply of Stelara 90 mg/mL syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 10, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite...
- SPE2DB24D9155Indefinite Delivery Contract
- SPE2DB24D9155-SPE2DB25FHZHSDelivery Order
The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established capabilities as a federal pharmaceutical supplier. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. Stelara is a biologic medication used to treat various autoimmune and inflammatory conditions. Through this IDC vehicle, the Defense Logistics Agency maintains access to a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized pharmaceutical products to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/10/25 |